<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30062571</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>18</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1573-7217</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>172</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                    </PubDate>                </JournalIssue>                <Title>Breast cancer research and treatment</Title>                <ISOAbbreviation>Breast Cancer Res. Treat.</ISOAbbreviation>            </Journal>            <ArticleTitle>Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema.</ArticleTitle>            <Pagination>                <MedlinePgn>83-91</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10549-018-4902-z</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Despite increasing emphasis on screening and early intervention for breast cancer-related lymphedema (BCRL), there is marked heterogeneity in diagnostic methodology, including for volumetric measures. This retrospective study compared two volumetric modalities, perometry and simulated circumferential tape measurement (anatomic- and interval-based), for BCRL detection.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Between 2005 and 2017, 287 female patients with unilateral breast cancer were prospectively screened for BCRL by perometry and the relative volume change (RVC) formula. Circumferential measurement was performed by sampling at five anatomic landmark-based points or 4-cm intervals from pairs of perometer arm diameter measurements. Volumetric conversion was by a frustum model. The Bland-Altman method was used to compare segmental volume differences. Confusion matrix analysis was performed for each circumferential measurement technique against perometry.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Median follow-up was 34.7 months over 4 postoperative visits. There was no difference in total arm volume comparing any of the circumferential measurement techniques to perometry. Landmark-based methods significantly underestimated upper arm volume (mean difference - 207 mL [- 336, - 78 mL]) and overestimated forearm volume (mean difference + 170 mL [+ 105, + 237 mL]). Landmark-based methods had greater sensitivity and specificity compared to 4-cm interval methods for detection of both RVC ≥ 10 and 5-10%. Landmark-based methods were comparable to perometry for detection of RVC ≥ 10%, but sensitivity was only 63.2-66.7% for RVC 5-10%.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This hypothesis-generating study suggested the superiority of anatomic landmark-based circumferential tape measurement compared to interval-based methods, while generating questions about the underestimation of upper arm volume and overestimation of forearm volume of circumferential tape measurement compared to perometry.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Sun</LastName>                    <ForeName>Fangdi</ForeName>                    <Initials>F</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5917-6209</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, MA, 02114, USA. fangdisun@gmail.com.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Hall</LastName>                    <ForeName>Alexander</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, MA, 02114, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tighe</LastName>                    <ForeName>Megan P</ForeName>                    <Initials>MP</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, MA, 02114, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brunelle</LastName>                    <ForeName>Cheryl L</ForeName>                    <Initials>CL</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Physical and Occupational Therapy, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, MA, 02114, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sayegh</LastName>                    <ForeName>Hoda E</ForeName>                    <Initials>HE</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, MA, 02114, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gillespie</LastName>                    <ForeName>Tessa C</ForeName>                    <Initials>TC</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, MA, 02114, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Daniell</LastName>                    <ForeName>Kayla M</ForeName>                    <Initials>KM</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, MA, 02114, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Taghian</LastName>                    <ForeName>Alphonse G</ForeName>                    <Initials>AG</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, MA, 02114, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>R01 CA139118</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>R01CA139118</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>P50CA08393</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Breast Cancer Res Treat</MedlineTA>            <NlmUniqueID>8111104</NlmUniqueID>            <ISSNLinking>0167-6806</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2017 Oct;24(10):2818-2826</RefSource>                <PMID Version="1">28766232</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Surg. 2016 Jan;211(1):133-41</RefSource>                <PMID Version="1">26421413</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2016 Jun;157(2):229-240</RefSource>                <PMID Version="1">27154787</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Med. 2016 Jun;5(6):1154-62</RefSource>                <PMID Version="1">26993371</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lymphat Res Biol. 2005;3(4):208-17</RefSource>                <PMID Version="1">16379589</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2012 Aug;135(1):145-52</RefSource>                <PMID Version="1">22710706</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lymphat Res Biol. 2017 Dec;15(4):349-355</RefSource>                <PMID Version="1">28956701</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Crit Rev Oncol Hematol. 2014 Dec;92(3):227-34</RefSource>                <PMID Version="1">25085806</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lymphology. 2013 Mar;46(1):1-11</RefSource>                <PMID Version="1">23930436</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pers Med. 2015 May 20;5(2):153-64</RefSource>                <PMID Version="1">26011383</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2012 Aug;19(8):2580-9</RefSource>                <PMID Version="1">22395997</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nurs Res. 2003 Nov-Dec;52(6):370-9</RefSource>                <PMID Version="1">14639083</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lymphology. 2007 Mar;40(1):35-46</RefSource>                <PMID Version="1">17539463</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2017 Dec;36:67-73</RefSource>                <PMID Version="1">28992556</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PM R. 2011 Dec;3(12):1098-1105</RefSource>                <PMID Version="1">21974905</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2013 May;14(6):500-15</RefSource>                <PMID Version="1">23540561</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lymphat Res Biol. 2015 Mar;13(1):33-9</RefSource>                <PMID Version="1">25668060</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Vasc Endovasc Surg. 1996 Nov;12(4):412-7</RefSource>                <PMID Version="1">8980428</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2013 Aug;140(3):485-94</RefSource>                <PMID Version="1">23912961</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1436-43</RefSource>                <PMID Version="1">20605339</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2012 Jun;21(3):314-20</RefSource>                <PMID Version="1">22342676</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lymphology. 2010 Sep;43(3):118-27</RefSource>                <PMID Version="1">21226414</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Semin Radiat Oncol. 2003 Jul;13(3):214-25</RefSource>                <PMID Version="1">12903011</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Malawi Med J. 2012 Sep;24(3):69-71</RefSource>                <PMID Version="1">23638278</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pers Med. 2015 Sep 30;5(4):341-53</RefSource>                <PMID Version="1">26437431</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Support Care Cancer. 2005 Nov;13(11):904-11</RefSource>                <PMID Version="1">15812652</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Intern Med. 2013 Jan;24(1):59-62</RefSource>                <PMID Version="1">22964259</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Nurs Forum. 2014 Sep;41(5):473-83</RefSource>                <PMID Version="1">25158653</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Psychooncology. 2010 Mar;19(3):299-305</RefSource>                <PMID Version="1">19399782</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Pers Med. 2014 Aug 18;4(3):424-47</RefSource>                <PMID Version="1">25563360</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2788-97</RefSource>                <PMID Version="1">9874399</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2011 Dec 10;29(35):4647-53</RefSource>                <PMID Version="1">22067407</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lymphology. 2013 Sep;46(3):132-43</RefSource>                <PMID Version="1">24645536</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Phys Ther. 2017 Jul 1;97(7):729-745</RefSource>                <PMID Version="1">28838217</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lymphat Res Biol. 2018 Aug;16(4):368-376</RefSource>                <PMID Version="1">29338541</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Phys Ther. 2018 Jun 1;98(6):510-517</RefSource>                <PMID Version="1">29361079</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">Edema</Keyword>            <Keyword MajorTopicYN="N">Lymphedema</Keyword>            <Keyword MajorTopicYN="N">Quantification</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>20</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>11</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>1</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30062571</ArticleId>            <ArticleId IdType="doi">10.1007/s10549-018-4902-z</ArticleId>            <ArticleId IdType="pii">10.1007/s10549-018-4902-z</ArticleId>            <ArticleId IdType="pmc">PMC6191334</ArticleId>            <ArticleId IdType="mid">NIHMS1502083</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>